Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Malignant Lymphoma

  Free Subscription


07.10.2019

1 Am J Surg Pathol
4 Blood
1 Bone Marrow Transplant
3 Br J Haematol
1 Cancer
2 J Clin Oncol
3 Leuk Lymphoma
1 Leukemia
1 Mod Pathol
1 Nat Rev Cancer


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Surg Pathol

  1. XU ML, Gabali A, Hsi ED, Fedoriw Y, et al
    Practical Approaches on CD30 Detection and Reporting in Lymphoma Diagnosis.
    Am J Surg Pathol. 2019 Sep 26. doi: 10.1097/PAS.0000000000001368.
    PubMed     Text format     Abstract available


    Blood

  2. AMADOR C, Greiner TC, Heavican TB, Smith LM, et al
    Reproducing the Molecular Subclassification of Peripheral T-cell Lymphoma-NOS by Immunohistochemistry.
    Blood. 2019 Sep 27. pii: blood.2019000779. doi: 10.1182/blood.2019000779.
    PubMed     Text format     Abstract available

  3. SUKSWAI N, Thirabanjasak D
    B-lymphoblastic leukemia/lymphoma with an unusual appendiceal involvement.
    Blood. 2019;134:1110.
    PubMed     Text format    

  4. PANEA RI, Love CL, Shingleton JR, Reddy A, et al
    The whole genome landscape of Burkitt lymphoma subtypes.
    Blood. 2019 Sep 26. pii: blood.2019001880. doi: 10.1182/blood.2019001880.
    PubMed     Text format     Abstract available

  5. LUNNING M, Vose J, Nastoupil L, Fowler N, et al
    Ublituximab and Umbralisib in Relapsed/ Refractory B-cell Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia.
    Blood. 2019 Sep 26. pii: blood.2019002118. doi: 10.1182/blood.2019002118.
    PubMed     Text format     Abstract available


    Bone Marrow Transplant

  6. SUREDA A, Chabannon C, Masszi T, Pohlreich D, et al
    Analysis of data collected in the European Society for Blood and Marrow Transplantation (EBMT) Registry on a cohort of lymphoma patients receiving plerixafor.
    Bone Marrow Transplant. 2019 Sep 30. pii: 10.1038/s41409-019-0693.
    PubMed     Text format     Abstract available


    Br J Haematol

  7. DI RAIMONDO C, Abdulla FR, Zain J, Querfeld C, et al
    Rituximab, lenalidomide and pembrolizumab in refractory primary cutaneous diffuse large B-cell lymphoma, leg type.
    Br J Haematol. 2019 Sep 30. doi: 10.1111/bjh.16211.
    PubMed     Text format    

  8. CASTELLINO SM, Parsons SK, Kelly KM
    Closing the survivorship gap in children and adolescents with Hodgkin lymphoma.
    Br J Haematol. 2019 Sep 30. doi: 10.1111/bjh.16197.
    PubMed     Text format     Abstract available

  9. GARCIA-MUNOZ R, Quero C, Perez-Persona E, Domingo-Garcia A, et al
    Safety of switching from intravenous to subcutaneous rituximab during first-line treatment of patients with non-Hodgkin lymphoma: the Spanish population of the MabRella study.
    Br J Haematol. 2019 Oct 1. doi: 10.1111/bjh.16227.
    PubMed     Text format     Abstract available


    Cancer

  10. AYERS EC, Li S, Medeiros LJ, Bond DA, et al
    Outcomes in patients with aggressive B-cell non-Hodgkin lymphoma after intensive frontline treatment failure.
    Cancer. 2019 Sep 30. doi: 10.1002/cncr.32526.
    PubMed     Text format     Abstract available


    J Clin Oncol

  11. KOBE C, Goergen H, Fuchs M, Muller H, et al
    Predictive Value of Positron Emission Tomography/Computed Tomography After ABVD-Based Chemotherapy in Early-Stage Hodgkin Lymphoma.
    J Clin Oncol. 2019 Sep 30:JCO1901761. doi: 10.1200/JCO.19.01761.
    PubMed     Text format    

  12. ADAMS HJA, Kwee TC
    Only a Small Proportion of Patients With Early-Stage Hodgkin Lymphoma May Potentially Benefit From Fluorodeoxyglucose-Positron Emission Tomography-Adapted Treatment Escalation.
    J Clin Oncol. 2019 Sep 30:JCO1901491. doi: 10.1200/JCO.19.01491.
    PubMed     Text format    


    Leuk Lymphoma

  13. HERBER M, Mertz P, Dieudonne Y, Guffroy B, et al
    Primary immunodeficiencies and lymphoma: a systematic review of literature.
    Leuk Lymphoma. 2019 Oct 3:1-11. doi: 10.1080/10428194.2019.1672056.
    PubMed     Text format     Abstract available

  14. MYLES N, Giri P, Chim I, Kodituwakku A, et al
    The utility of CD200 expression and modified Matutes score in the diagnostic differentiation of mantle cell lymphoma and chronic lymphocytic leukemia using flow cytometry.
    Leuk Lymphoma. 2019 Sep 27:1-3. doi: 10.1080/10428194.2019.1663420.
    PubMed     Text format    

  15. PORRATA LF
    Beware of the neutrophil/lymphocyte ratio in diffuse large B-cell lymphoma.
    Leuk Lymphoma. 2019 Sep 26:1-2. doi: 10.1080/10428194.2019.1668940.
    PubMed     Text format    


    Leukemia

  16. WANG M, Rule S, Zinzani PL, Goy A, et al
    Durable response with single-agent acalabrutinib in patients with relapsed or refractory mantle cell lymphoma.
    Leukemia. 2019 Sep 26. pii: 10.1038/s41375-019-0575.
    PubMed     Text format    


    Mod Pathol

  17. LAGINESTRA MA, Cascione L, Motta G, Fuligni F, et al
    Correction: Whole exome sequencing reveals mutations in FAT1 tumor suppressor gene clinically impacting on peripheral T-cell lymphoma not otherwise specified.
    Mod Pathol. 2019 Sep 26. pii: 10.1038/s41379-019-0376.
    PubMed     Text format     Abstract available


    Nat Rev Cancer

  18. SETON-ROGERS S
    How the brain retains lymphoma cells.
    Nat Rev Cancer. 2019 Sep 30. pii: 10.1038/s41568-019-0214.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Malignant Lymphoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: